Abstract
Alkaptonuria is a rare autosomal-recessive disorder that produces accumulation of homogentisic acid in body fluids. The accumulation in collagen tissues, mainly in the joint cartilage, produces ochronotic arthropathy. We report two clinical cases of one brother and sister with alkaptonuria and ochronotic arthropathy diagnosed in old age. In the first case, the patient is diagnosed by musculoskeletal involvement with long-term low back pain with other associated manifestations that made this pathology suspected. In the second case, the patient comes due to osteoporosis and other associated fractures and with the family history and the rest of the clinic, the appropriate complementary tests were performed and the diagnosis is established. It is unknown if there is consanguinity in these patients between parents or ancestors. It is an infrequent pathology that is often diagnosed intraoperatively. Despite the poor efficacy of medical treatment, it would be advisable to make an early diagnosis to avoid accumulation of the pigment and accelerated joint destruction and deposition in other locations. Owing to its prevalence, it is difficult to find a significant number of patients to search for new treatments that are intended to correct the enzyme deficit and not only to modify the elimination.
Similar content being viewed by others
References
Srsen S, Cisarik F, Pasztor L, Harmecko L (1978) Alkaptonuria in the Trencin District of Czechoslovakia. Am J Med Genet 2:159–166. https://doi.org/10.1002/ajmg.1320020207
Milch RA (1960) Studies of alcaptonuria: inheritance of 47 genes in highly inter-related Dominican kindreds. Am J Hum Genet 12:76–85
Toth K, Kiss-Láaszló Z, Lénárt E et al (2010) Familiar ochronotic arthropathy-caused by a gene mutation traced 300 years. Jt Bone Spine 77:355–357. https://doi.org/10.1016/j.jbspin.2010.03.007
O’Brien M, La Du BN, Bunim J (1963) Biochemical, pathologic and clinical aspects of alcaptonuria, ochronosis, and ochronotic arthropathy. Am J Med 34:813–838. https://doi.org/10.1016/0002-9343(63)90089-5
Garrod AE (1901) About alkaptonuria. Lancet 158:1484–1486
Fernández-Cañón JM, Granadino B, de Beltrán-Valero Bernabé D, Renedo M, Fernández-Ruiz E et al (1996) The molecular basis of alkaptonuria. Nat Genet 14:19–24. https://doi.org/10.1038/ng0996-19
Phornphutkul C, Introne WJ, Perry MB, Bernardini I, Murphey MD et al (2002) Natural history of alkaptonuria. New Eng J Med 347:2111–2121. https://doi.org/10.1056/NEJMoa021736
Lichtestein L, Kaplan L (1954) Hereditary ochronosis. Pathologic changes observed in two necropsied cases. Am J Pathol 30:99–125
Gaines JJ, Ganesh MP (1987) Cardiovascular ochronosis. Arch Pathol Lab Med 111:991–994
Helou J, Masters RG, Keon WJ, Venoit JP (1999) Ochronosis: an unusual finding at aortic valve replacement. Can J Cardiol 15:1013–1015
Mannoni A, Selvi E, Lorenzini S et al (2004) Alkaptonuria, ochronosis, and ochronotic arthropathy. Semin Arthritis Rheum 33(4):239–248. https://doi.org/10.1053/S0049-0172(03)00080-5
Kalevski SK, Haritonov DG, Peev NA (2007) Alcaptonuria with lumbar disc prolapse: case study and review of the literature. Spine J 7(4):495–498. https://doi.org/10.1016/j.spinee.2006.06.399
Reddy DR, Prasad VS (1998) Alkaptonuria presenting as lumbar disc prolapse: case report and review of literature. Spinal Cord 36(7):523–524. https://doi.org/10.1038/sj.sc.3100562
Akbaba AI, Ozgül RK, Dursun A (2020) Presentation of 14 alkaptonuria patients from Turkey. J Pediatr Endocrinol Metab 33(2):289–294. https://doi.org/10.1515/jpem-2019-0163
Şahin Günşah, Milcan Abtullah, Bagis Selda, Köktürk Ayşin, Pata Cengiz, Erdoğan Canan (2001) A case of ochronosis: upper extremity involvement. Rheumatol Int 21:78–80. https://doi.org/10.1007/s002960100136
Schumacher HR, Holdsworth DE (1977) Ochronotic arthropathy. I. Clinicopathologic studies. Semin Arthritis Rheum 6:207–246
McClure J, Smith PS, Gramp AA (1983) Calcium pyrophosphate dehydrate (CPPD) deposition in ochronotic arthropathy. J Clin Pathol 36:894–902. https://doi.org/10.1136/jcp.36.8.894
Hamdi N, Cooke TDV, Hassan B (1999) Ochronotic arthropathy: case report and review of the literature. Int Orthop 23:122–250. https://doi.org/10.1007/s002640050325
Kocyigit H, Gurgan A, Terzioglu R, Gurgan U (1998) Clinical, radiological and echocardiographic findings in a patient with ochronosis. Clin Rheum 17:403–406. https://doi.org/10.1007/bf01450903
Wolff JA, Barshop B, Nyhan WL, Leslie J, Seegmiller JE, Gruber H et al (1989) Effects of ascorbic acid in alkaptonuria: alterations in benzoquinone acetic acid and ontogenic effect in infancy. Pediatr Res 26:140–144. https://doi.org/10.1203/00006450-198908000-00015
De Haas V, Carbasius Weber EC, de Klerk JB, Bakker HD, Smit GP, Huijbers WA et al (1998) The success of dietary protein restriction in alkaptonuria patients is age-dependent. J Inherit Metab Dis 21:791–798. https://doi.org/10.1023/a:1005410416482
Mistry JB, Bukhari M, Taylor AM (2013) Alkaptonuria. Rare Dis. https://doi.org/10.4161/rdis.27475
Morava E, Kosztolányi G, Engelke UF et al (2003) Reversal of clinical symptoms and radiographic abnormalities with protein restriction and ascorbic acid in alkaptonuria. Ann Clin Biochem 40(Pt 1):108–111. https://doi.org/10.1258/00045630332101626
Forslind K, Wollheim F, Akesson B, Rydholm U (1988) Alkaptonuria and ochronosis in three siblings. Ascorbic acid treatment monitored by urinary HGA excretion. Clin Exp Rheum 6:289–292
Suwannarat P, O’Brien K, Perry MB et al (2005) Use of nitisinone in patients with alkaptonuria. Metabolism 54(6):719–728. https://doi.org/10.1016/j.metabol.2004.12.017
Ranganath LR, Milan AM, Hughes AT et al (2016) Suitability Of Nitisinone In Alkaptonuria 1 (SONIA 1): an international, multicentre, randomised, open-label, no-treatment controlled, parallel-group, dose-response study to investigate the effect of once daily nitisinone on 24-h urinary homogentisic acid excretion in patients with alkaptonuria after 4 weeks of treatment. Ann Rheum Dis 75:362–367. https://doi.org/10.1136/annrheumdis-2014-206033
Zeybek CA, Zubarioglu T (2017) Nitisinone: a review. Orphan Drugs Res Rev 7:25–35. https://doi.org/10.2147/ODRR.S92995
Introne WJ, Perry MB, Troendle J, Tsilou E, Kayser MA, Suwannarat P, O’Brien KE, Bryant J, Sachdev V, Reynolds JC, Moylan E, Bernardini I, Gahl WA (2011) A 3-year randomized therapeutic trial of nitisinone in alkaptonuria. Mol Genet Metab 103(4):307–314. https://doi.org/10.1016/j.ymgme.2011.04.016
Demir S (2003) Alkaptonuric ochronosis: a case with multiple joint replacement arthroplasties. Clin Rheumatol 22:437–439
Wu K, Bauer E, Myung G, Fang MA (2018) Musculoskeletal manifestations of alkaptonuria: a case report and literature review. Eur J Rheumatol 6(2):98–101. https://doi.org/10.5152/eurjrheum.2018.18116
Couto A, Sá Rodrigues A, Oliveira P, Seara M (2018) Ochronotic arthropathy—a rare clinical case. Oxf Med Case Rep. https://doi.org/10.1093/omcr/omy069
Acknowledgements
Dr. M. Aguilar González (Hospital Universitario La Fe, Valencia, Spain) for image editing. E. Aristoy Gómez-Lechón (Hospital Universitario La Fe, Valencia, Spain) for English editing.
Author information
Authors and Affiliations
Contributions
All the authors have participated in the bibliographic search and preparation of the following manuscript; LGQ: bibliographic search, case acquisition and writing—original draft; CHC: bibliographic search, review and editing; MEAV: bibliographic search and writing; OCF: bibliographic search and imaging; SPN: bibliographic search; CMM: editing, supervision, review.
Corresponding author
Ethics declarations
Conflict of interest
We know no conflicts of interest associated with this publication, and there has been no financial support for this work that could have influenced its outcome.
Ethical statement
All mandatory laboratory health and safety procedures have been complied with in the course of conducting any experimental work reported in the manuscript. We declare that this manuscript is original, has not been published before and is not currently being considered for publication elsewhere. As Corresponding Author, I confirm that the manuscript has been read and approved for submission by all the named authors with subsequent modifications. All authors approved the final manuscript as submitted and agree to be accountable for all aspects of the work. The publication is approved following the guidelines of the ethical committee of the University Hospital of Salamanca (CEIM Hospital Universitario de Salamanca. Ref: E.O. 19/743 EPA-OD 19 10/02/20).
Informed consent
The patient involved agrees to include their clinical data for the publication of the case report.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Gómez-Lechón Quirós, L., Hidalgo Calleja, C., Acosta de la Vega, M.E. et al. Family history of ochronotic arthropathy. Rheumatol Int 41, 1869–1874 (2021). https://doi.org/10.1007/s00296-020-04640-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00296-020-04640-2